Skip to main content

Guttmacher Institute

Donate Now

Highlights

  • Roe v. Wade in Peril
  • COVID-19 impact
  • Reproductive Health Impact Study
  • Adding It Up
  • Abortion Worldwide
  • Guttmacher-Lancet Commission
  • U.S. policy resources
  • State policy resources
  • State legislation tracker

Reports

  • Global
  • U.S.

Articles

  • Global research
  • U.S. research
  • Policy analysis
  • Guttmacher Policy Review
  • Op-eds & external blogs

Fact Sheets

  • Global
  • U.S.
  • U.S. State Laws and Policies

Data & Visualizations

  • Data center
  • Infographics
  • Public-use data sets

Peer-Reviewed Journals

  • International Perspectives on Sexual and Reproductive Health
  • Perspectives on Sexual and Reproductive Health

Global

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

U.S.

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

Our Work By Geography

  • Global
  • Africa
  • Asia
  • Europe
  • Latin America & the Caribbean
  • Northern America
  • Oceania

Who We Are

  • About
  • Staff
  • Board
  • Job opportunities
  • History
  • Contact
  • Conflict of Interest Policy

Media

  • Media office
  • News releases

Support Our Work

  • Make a gift today
  • Monthly Giving Circle
  • Donate stock or securites
  • Guttmacher Legacy Circle
  • Financials
  • Annual Report

Awards and Scholarships

  • Darroch Award
  • Richards Scholarship
  • Bixby Fellowship

Search form

Good reproductive health policy starts with credible research

 

Connect With Us

  • Facebook
  • Instagram
  • Twitter
  • Email
Guttmacher Institute

Good reproductive health policy starts with credible research

 

Donate Now

Connect With Us

  • Facebook
  • Instagram
  • Twitter
  • Email

Highlights

  • Roe v. Wade in Peril
  • COVID-19 impact
  • Reproductive Health Impact Study
  • Adding It Up
  • Abortion Worldwide
  • Guttmacher-Lancet Commission
  • U.S. policy resources
  • State policy resources
  • State legislation tracker

Reports

  • Global
  • U.S.

Articles

  • Global research
  • U.S. research
  • Policy analysis
  • Guttmacher Policy Review
  • Op-eds & external blogs

Fact Sheets

  • Global
  • U.S.
  • U.S. State Laws and Policies

Data & Visualizations

  • Data center
  • Infographics
  • Public-use data sets

Peer-Reviewed Journals

  • International Perspectives on Sexual and Reproductive Health
  • Perspectives on Sexual and Reproductive Health

Global

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

U.S.

  • Abortion
  • Contraception
  • HIV & STIs
  • Pregnancy
  • Teens

Our Work By Geography

  • Global
  • Africa
  • Asia
  • Europe
  • Latin America & the Caribbean
  • Northern America
  • Oceania

Who We Are

  • About
  • Staff
  • Board
  • Job opportunities
  • History
  • Contact
  • Conflict of Interest Policy

Media

  • Media office
  • News releases

Support Our Work

  • Make a gift today
  • Monthly Giving Circle
  • Donate stock or securites
  • Guttmacher Legacy Circle
  • Financials
  • Annual Report

Awards and Scholarships

  • Darroch Award
  • Richards Scholarship
  • Bixby Fellowship

Search form

Global

HIV & STIs

The Guttmacher Institute’s international work on HIV and other STIs focuses on developing regions. Our research and advocacy efforts have focused on the linkages between HIV and sexual and reproductive health and rights, the impact of STIs on maternal and newborn health, the need for new technologies (including multipurpose prevention technologies) and U.S. support for global AIDS programs. 

  • Fact Sheet

    Investing in Sexual and Reproductive Health in Low- and Middle-Income Countries

  • Policy Analysis

    The COVID-19 Outbreak: Potential Fallout for Sexual and Reproductive Health and Rights

  • Policy Analysis

    Just $10 Per Person a Year Could Provide Sexual and Reproductive Health Services to All—Will the United States Help Make That Happen?

Top Facts & Statistics

  • 6.6M

    women in developing regions have an unmet need for antiretroviral therapy
  • $10.60

    the annual per-person cost in LMICs to meet the need for essential sexual and reproductive health services
  • 1 in 3

    pregnant women in the developing world living with HIV receive no antiretroviral medication

Resources

  • July 2020 Fact Sheet

    Investir dans la santé sexuelle et reproductive dans les pays à revenu faible ou intermédiaire

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy
    • Teens
  • July 2020 News Release

    La provisión de servicios esenciales de salud sexual y reproductiva reduciría en cerca de dos tercios los embarazos no planeados, los abortos inseguros y las muertes maternas

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy
    • Teens
  • July 2020 Fact Sheet

    Investing in Sexual and Reproductive Health in Low- and Middle-Income Countries

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy
    • Teens
  • July 2020 Report

    Vue d’ensemble: investir dans la santé sexuelle et reproductive 2019—Résumé

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy
    • Teens
  • June 2020 Research Article

    Budgeting for comprehensive sexual and reproductive health and rights under universal health coverage

    Naomi Lince-Deroche, Elizabeth A. Sully, Lauren Firestein and Taylor Riley,Sexual and Reproductive Health Matters

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy
  • April 2020 Research Article

    Estimaciones del impacto potencial de la pandemia COVID-19 en la salud sexual y reproductiva en países de ingreso bajo y mediano

    Taylor Riley, Elizabeth A. Sully, Zara Ahmed and Ann Biddlecom,International Perspectives on Sexual and Reproductive Health

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy
  • April 2020 Research Article

    Estimaciones del impacto potencial de la pandemia COVID-19 en la salud sexual y reproductiva en países de ingreso bajo y mediano

    Taylor Riley, Elizabeth A. Sully, Zara Ahmed and Ann Biddlecom,International Perspectives on Sexual and Reproductive Health

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy
  • April 2020 Research Article

    Estimaciones del impacto potencial de la pandemia COVID-19 en la salud sexual y reproductiva en países de ingreso bajo y mediano

    Taylor Riley, Elizabeth A. Sully, Zara Ahmed and Ann Biddlecom,International Perspectives on Sexual and Reproductive Health

    Global

    • Abortion
    • Contraception
    • HIV & STIs
    • Pregnancy
  • November 2019 Policy Analysis

    The Integration of Family Planning and HIV Services: Fulfilling Our Promises to Young Women

    Zara Ahmed

    Global

    • HIV & STIs
    • Teens
  • September 2019 Blog / Letter / Op-ed

    World Contraception Day: Celebrating Progress and Maintaining Momentum

    Heather D. Boonstra and Leah H. Keller,IMPT Blog

    Global

    • Contraception
    • HIV & STIs

Pages

  • « first
  • ‹ previous
  • …
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • next ›
  • last »
Explore the Data Center

Hear From An Expert

Supporting and adequately funding the development of multipurpose prevention technologies (MPTs) should be a higher priority for the U.S. government, especially at a time when private sector support is missing. Unfortunately, current funding—while critical in advancing this important work to date—has not been sufficient. This inadequate funding may significantly hamper the timely development of MPTs that could be a huge boost to achieving U.S. global health priorities

Heather D. Boonstra

Vice President for Public Policy

Select a country profile

Guttmacher Institute
Reproductive rights are under attack. Will you help us fight back with facts?
Donate Now
Follow Guttmacher:

Connect With Us

  • Facebook
  • Instagram
  • Twitter
  • YouTube
  • LinkedIn

Footer Menu

  • Privacy Policy
© 2022 Guttmacher Institute. The Guttmacher Institute is registered as a 501(c)(3) nonprofit organization under the tax identification number 13-2890727. Contributions are tax deductible to the fullest extent allowable.

Get Our Updates